Cargando…
Drug resistance mechanism and reversal strategy in lung cancer immunotherapy
Among all malignant tumors, lung cancer has the highest mortality and morbidity rates. The non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the most common histological subtypes. Although there are a number of internationally recognized lung cancer therapy regimens, their the...
Autores principales: | Xu, Yishi, Liu, Yaqing, Ge, Yi, Li, Haozhe, Zhang, Yi, Wang, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546211/ https://www.ncbi.nlm.nih.gov/pubmed/37795038 http://dx.doi.org/10.3389/fphar.2023.1230824 |
Ejemplares similares
-
Therapy resistance in neuroblastoma: Mechanisms and reversal strategies
por: Zhou, Xia, et al.
Publicado: (2023) -
The Application of and Strategy for Gold Nanoparticles in Cancer Immunotherapy
por: He, Jia-shuai, et al.
Publicado: (2021) -
Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer
por: Huang, Lu, et al.
Publicado: (2022) -
Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
por: Zheng, Wujian, et al.
Publicado: (2017) -
Traditional Chinese Medicines as Effective Reversals of Epithelial-Mesenchymal Transition Induced-Metastasis of Colorectal Cancer: Molecular Targets and Mechanisms
por: Ge, Hongzhang, et al.
Publicado: (2022)